Merck (MRK) Receivables (2009 - 2026)

Merck (MRK) has 18 years of Receivables data on file, last reported at $12.2 billion in Q1 2026.

• Receivables for Q1 2026 came in at $12.2 billion, up 13.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 billion (up 13.16% YoY), and the FY2025 annual result was $11.8 billion, up 14.57% from the prior year.
• Receivables improved to $12.2 billion in Q1 2026 per MRK's latest filing, from $11.8 billion in the prior quarter.
• Over five years, Receivables peaked at $12.2 billion in Q1 2026 and troughed at $260.0 million in Q3 2023.
• A 5-year average of $8.7 billion and a median of $10.9 billion in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2023 and 2024: Receivables sank 69.66% in 2023, then jumped 4277.31% in 2024.
• A 5-year view of Receivables shows it stood at $10.0 billion in 2022, then gained by 3.9% to $10.3 billion in 2023, then declined by 0.69% to $10.3 billion in 2024, then gained by 14.57% to $11.8 billion in 2025, then climbed by 3.69% to $12.2 billion in 2026.
• Business Quant data shows MRK's Receivables at $12.2 billion in Q1 2026, $11.8 billion in Q4 2025, and $12.1 billion in Q3 2025.